Ghamrawi RI - Search Results

1

Receptivity to misinformation is associated with a preference for complementary alternative medicine for atopic dermatitis.

Pham Q, Hrin ML, Ghamrawi RI, Fleischer AB Jr, Taylor SL, Feldman SR. Pham Q, et al. Among authors: ghamrawi ri. Int J Dermatol. 2024 Jun;63(6):e119-e120. doi: 10.1111/ijd.17143. Epub 2024 Apr 4. Int J Dermatol. 2024. PMID: 38572810 No abstract available.

2

Placebo tailoring improves patient satisfaction of treatment plans in atopic dermatitis.

Bashyam AM, Cuellar-Barboza A, Ghamrawi RI, Feldman SR. Bashyam AM, et al. Among authors: ghamrawi ri. J Am Acad Dermatol. 2020 Sep;83(3):944-946. doi: 10.1016/j.jaad.2020.01.044. Epub 2020 Jan 28. J Am Acad Dermatol. 2020. PMID: 32004644 Free PMC article. No abstract available.

3

Pharmacological management of atopic dermatitis in the elderly.

Howell AN, Ghamrawi RI, Strowd LC, Feldman SR. Howell AN, et al. Among authors: ghamrawi ri. Expert Opin Pharmacother. 2020 May;21(7):761-771. doi: 10.1080/14656566.2020.1729738. Epub 2020 Feb 26. Expert Opin Pharmacother. 2020. PMID: 32100586

4

Treatment Goals in Psoriasis: Which Outcomes Matter Most?

Svoboda SA, Ghamrawi RI, Owusu DA, Feldman SR. Svoboda SA, et al. Among authors: ghamrawi ri. Am J Clin Dermatol. 2020 Aug;21(4):505-511. doi: 10.1007/s40257-020-00521-3. Am J Clin Dermatol. 2020. PMID: 32424692 Review.

5

Current and emerging biologics for the treatment of pediatric atopic dermatitis.

Ghamrawi R, Bell KA, Balogh EA, Strowd LC, Feldman SR. Ghamrawi R, et al. Expert Opin Biol Ther. 2020 Dec;20(12):1435-1445. doi: 10.1080/14712598.2021.1840548. Epub 2020 Nov 15. Expert Opin Biol Ther. 2020. PMID: 33078990 Review.

6

Immunogenicity of Biologic and Biosimilar Therapies for Psoriasis and Impact of Novel Immunoassays for Immunogenicity Detection.

Heron CE, Ghamrawi RI, Balogh EA, Feldman SR. Heron CE, et al. Among authors: ghamrawi ri. Am J Clin Dermatol. 2021 Mar;22(2):221-231. doi: 10.1007/s40257-020-00569-1. Epub 2020 Nov 9. Am J Clin Dermatol. 2021. PMID: 33169802 Review.

7

Controversial cardiovascular and hematologic comorbidities in atopic dermatitis.

Pandher K, Ghamrawi RI, Heron CE, Feldman SR. Pandher K, et al. Among authors: ghamrawi ri. Arch Dermatol Res. 2022 May;314(4):317-324. doi: 10.1007/s00403-021-02240-z. Epub 2021 May 10. Arch Dermatol Res. 2022. PMID: 33973062 Review.

8

Emerging Role of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis.

Singh R, Heron CE, Ghamrawi RI, Strowd LC, Feldman SR. Singh R, et al. Among authors: ghamrawi ri. Immunotargets Ther. 2020 Nov 10;9:255-272. doi: 10.2147/ITT.S229667. eCollection 2020. Immunotargets Ther. 2020. PMID: 33204661 Free PMC article. Review.

9

PrabotulinumtoxinA-xvfs for the Treatment of Moderate-to-Severe Glabellar Lines.

Gadarowski MB, Ghamrawi RI, Taylor SL, Feldman SR. Gadarowski MB, et al. Among authors: ghamrawi ri. Ann Pharmacother. 2021 Mar;55(3):354-361. doi: 10.1177/1060028020943527. Epub 2020 Jul 22. Ann Pharmacother. 2021. PMID: 32698599

10

A review of secukinumab in psoriasis treatment.

Berg SH, Balogh EA, Ghamrawi RI, Feldman SR. Berg SH, et al. Among authors: ghamrawi ri. Immunotherapy. 2021 Feb;13(3):201-216. doi: 10.2217/imt-2020-0195. Epub 2020 Nov 18. Immunotherapy. 2021. PMID: 33203276

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters